TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens
Clinical trial NCT02410772 · COMPLETED
Trial details
- NCT number
- NCT02410772
- Sponsor
- Centers for Disease Control and Prevention
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-25
- Primary completion
- 2020-07-01
- Enrollment
- 2516
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.